This content is from: United States The real deal: how pharma counsel spot counterfeit drugs Pharma counsel can look at suspicious packaging, online sellers and other signs to learn whether products are fake, say sources at Merck, Gilead and Organon By Rani Mehta May 20 2022
This content is from: China This week in IP: SCOTUS upholds Amazon win, hydrogen tech patents on rise, and more By Max Walters & Rani Mehta & Rory O’Neill & Sukanya Sarkar May 20 2022
This content is from: United States C-suite, marketing and sales: how in-house build relationships By Rani Mehta May 19 2022
This content is from: United States Managing sketchy emails: how counsel fight scams and spam By Rani Mehta May 19 2022
This content is from: China Creative thinking key to China lockdown woes, say counsel By Sukanya Sarkar May 18 2022
This content is from: International IP STARS 2022 edition: The leading IP practitioners By Chris Adams & Kingsley Egbuonu May 18 2022
This content is from: United Kingdom Opinion: Vogue trademark claim shows need for clear heads By Max Walters May 17 2022
This content is from: China Time to cash in on bargain buyback deals, say China TM counsel Even as bad-faith filers drop their prices, brand owners need to be wary of a stringent assignment process that might yet make the buyback process difficult By Sukanya Sarkar May 13 2022
